NXL-103, a combination of flopristin and linopristin, for the potential treatment of bacterial infections including community-acquired pneumonia and MRSA.
about
NXL-103, a combination of flopristin and linopristin, for the potential treatment of bacterial infections including community-acquired pneumonia and MRSA.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
NXL-103, a combination of flop ...... y-acquired pneumonia and MRSA.
@ast
NXL-103, a combination of flop ...... y-acquired pneumonia and MRSA.
@en
type
label
NXL-103, a combination of flop ...... y-acquired pneumonia and MRSA.
@ast
NXL-103, a combination of flop ...... y-acquired pneumonia and MRSA.
@en
prefLabel
NXL-103, a combination of flop ...... y-acquired pneumonia and MRSA.
@ast
NXL-103, a combination of flop ...... y-acquired pneumonia and MRSA.
@en
P2860
P1476
NXL-103, a combination of flop ...... ty-acquired pneumonia and MRSA
@en
P2093
Amani D Politano
Robert G Sawyer
P2860
P304
P577
2010-02-01T00:00:00Z